
Brian Lawson Is Named Executive Director Of The Board Of Pharmacy Specialties
"Dr. Lawson is a highly accomplished association management executive and credentialing leader. He's served BPS in a variety of roles over many years and is the perfect person to lead BPS into the future," said Michael D. Hogue, PharmD, FAPhA, FNAP, FFIP, Executive Vice President and CEO of APhA. "His track record of innovation, strategic vision, and collaboration with pharmacy professionals across the globe will ensure BPS continues to grow in its mission to improve patient care through board certification."
Lawson first joined BPS in 2012 and has held several senior positions, most recently serving as Associate Executive Director and previously as Senior Director of Professional Affairs and International Engagement. His leadership has been instrumental in expanding BPS's global footprint, strengthening governance and professional affairs, and elevating the visibility of board-certified pharmacists around the world. He has served on numerous national and international advisory committees and task forces, contributing his expertise to advance pharmacy practice and professional development globally.
With more than 60,000 active pharmacist certifications across 15 specialties, BPS sets the standard for board certification in pharmacy. Under Lawson's leadership, BPS is poised to build on its strong foundation and continue its mission of certifying pharmacists who advance patient care and clinical excellence.
Lawson succeeds William Ellis, who retired after 12 years of exemplary leadership as Executive Director of BPS.
For more information about BPS and its role in advancing pharmacy board certification, please visit . For more information on APhA and how it's advancing the entire pharmacy profession, please visit .
SOURCE American Pharmacists Association

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Comments
No comment